NCT00677573

Brief Summary

We proposed to compare outcomes in women with DOR undergoing ART with rec-FSH + u-HMH with those with u-FSH only in GnRH antagonist protocols.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2008

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2008

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

May 9, 2008

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 14, 2008

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2008

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2008

Completed
Last Updated

May 14, 2008

Status Verified

May 1, 2008

Enrollment Period

5 months

First QC Date

May 9, 2008

Last Update Submit

May 9, 2008

Conditions

Infertility

Keywords

ARTpoor responderGnRH antagonistGonadotropins

Outcome Measures

Primary Outcomes (1)

  • pregnancy rate per embryo transfer

    6 months

Secondary Outcomes (1)

  • number of oocytes retrieved

    per patient

Study Arms (1)

UrFSH

ACTIVE COMPARATOR
Drug: Fostimon

Interventions

FostimonDRUG

450 IU for 4 days then adjusted

UrFSH

Eligibility Criteria

Age20 Years - 44 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • At least one trial with adequate ovarian stimulation resulted by 4 or less oocytes retrieval.

You may not qualify if:

  • High responder patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alman Hastanesi

Istanbul, Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Central Study Contacts

Ulun Ulug, M.D.

CONTACT

90-21-2293-2150ulunulug@superonline.com

Mustafa Bahceci, M.D

CONTACT

90-21-2230-0809mbahceci@superonline.com

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 9, 2008

First Posted

May 14, 2008

Study Start

May 1, 2008

Primary Completion

October 1, 2008

Study Completion

November 1, 2008

Last Updated

May 14, 2008

Record last verified: 2008-05

Locations

TU(1)